Novel potent inhibitor of osteoclastogenesis, suppressing both equilibrative nucleoside transporters and concentrative nucleoside transporters

Novel inhibitor of airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease (COPD)

Antibacterial, inhibiting bacterial folic acid synthesis by competing with para amino benzoic acid

β-Lactam antibiotic against multi-drug resistant pathogens

Novel inhibitor of RhoG-hepcidin uptake

Neuroprotective agent, alleviating stroke-induced neuroinflammation

Peripheral vasodilator

Novel, potent, selective, and competitive antagonist of LTD4 and LTE4

D2 selective dopamine agonist, showing anxiolytic and anti-parkinsonian activities

Novel fibroblast growth factor receptor modulator for treating neurodegenerative diseases

5-HT2 antagonist

Potent Inhibitor of Plasmodium FK506 Binding Protein 35 (FKBD35), also act as a HIV inhibitor

Antagonist of the mammalian bile acid sensor farnesoid-X-receptor (FXR)

Selective D2 dopamine receptor antagonist

D2 dopamine receptor partial agonist in adenylyl cyclase inhibition assay and antagonist in the GIRK and phospho ERK1/2 assays

Novel clickable tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD)

Natural potent alpha-mannosidase inhibitor, exhibiting antimetastatic, antiproliferative, and immunomodulatory activities

Potent differentiating agent

Novel selective OXE receptor antagonist

Novel highly potent and selective CDK7 inhibitor, demonstrating broad anti-tumor activity in vivo

Novel universal opioid receptor agonist

Novel inhibitor of the Syk kinase (spleen tyrosine kinase)